|
Market Closed -
OTC Markets
09:51:35 20/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | - |
| 27/21/27 | Patient Access Solutions, Inc. Introduces CAMEO | CI |
| 24/21/24 | Cara Therapeutics Shares Rise 7% on FDA Approval of Korsuva Injection | DJ |
| Market Cap | 3L 3L 3L 3L 5L 3.35Cr 5L 33.12L 12.92L 1.68Cr 13.13L 12.85L 5.56Cr | P/E 2007 * |
-
| P/E 2008 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 13.85L 11.87L 11.1L 10.16L 19.08L 13Cr 19.33L 1.31Cr 51.16L 6.66Cr 52.02L 50.89L 22Cr | EV / Sales 2007 * |
-
| EV / Sales 2008 | 24.4x |
| Free-Float |
-
| Yield 2007 * |
-
| Yield 2008 | - |
| 1 week | 0 | 0 | |
| 1 month | 0 | 0 | |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0 | |
| 5 years | 0 | 0.01 | |
| 10 years | 0 | 0.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bruce Weitzberg
CEO | Chief Executive Officer | 66 | - |
Robert Linzalone
PRN | Corporate Officer/Principal | 66 | 02/02/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/04/26 | Other | 0 | 0% |
| 2007 | 2008 | |
|---|---|---|
| Net sales | 3L 3L 3L 2L 4L 3.09Cr 5L 30.55L 11.91L 1.55Cr 12.11L 11.85L 5.13Cr | 4L 3L 3L 3L 5L 3.35Cr 5L 33.18L 12.94L 1.68Cr 13.16L 12.87L 5.57Cr |
| Net income | -7L -6L -5L -5L -9L -6.56Cr -10L -64.89L -25.31L -3.29Cr -25.73L -25.17L -11Cr | -90.9L -77.87L -72.86L -66.69L -1.25Cr -87Cr -1.27Cr -8.61Cr -3.36Cr -44Cr -3.41Cr -3.34Cr -144.51Cr |
| Net Debt | 12.74L 10.91L 10.21L 9L 17.54L 12Cr 17.77L 1.21Cr 47.04L 6.12Cr 47.83L 46.79L 20Cr | 10.36L 9L 8L 8L 14.26L 9.91Cr 14.45L 98.07L 38.24L 4.98Cr 38.89L 38.04L 16Cr |
Employees
5
Sector
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/26/20 | $0.000001 | 0.00% | 60,000 |
- Stock Market
- Stocks
- PASO Stock
Select your edition
All financial news and data tailored to specific country editions
















